(Q40593923)
Statements
A novel strategy for the development of selective active-site inhibitors of the protein tyrosine phosphatase-like proteins islet-cell antigen 512 (IA-2) and phogrin (IA-2beta) (English)
Paul G Drake
Henrik Sune Andersen
Niels Peter H Møller
1 reference